ImmuCell (NASDAQ:ICCC – Get Rating) and Lucira Health (NASDAQ:LHDXQ – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, valuation, risk, dividends and analyst recommendations. Risk and Volatility ImmuCell has a beta of 0.66, indicating […]
ImmuCell Co. (NASDAQ:ICCC – Get Rating) crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $6.90 and traded as low as $5.00. ImmuCell shares last traded at $5.10, with a volume of 31,140 shares traded. Wall Street Analysts Forecast Growth Separately, […]